01
Body composition and sarcopenia assessment
Automatic detection and quantification of muscle mass in CT scans, providing crucial nutritional metrics for cancer patients and improving treatment efficacy.
Advanced AI-powered body composition analysis and tumor segmentation from medical images.
From scan to answer.
In seconds, not hours.
Our use cases
Nucleo's advanced AI technology streamlines clinical workflows across three critical areas for oncology care.
02
Tumor Lesion Sizing
Precise and consistent measurement of tumor lesions in CT scans, enabling accurate tracking of disease progression and treatment response.
03
Target vs Non-Target Lesion Classification
Automated classification of lesions according to RECIST criteria, streamlining the evaluation process and enhancing reporting consistency.
State of the art performance
Our platform delivers incredible performance in seconds. For example, in the body composition assessment task, our accuracy, measured in Dice score similarity, is well above that of the widely used Bioelectrical Impedance Analysis (BIA).
Our body composition tool
91%
The industry standard (BIA)
75%
Our lesion segmentator
85%
Get in touch
Interested in joining our pilot program or learning more about Nucleo? Reach out to us today.